Acadia Pharmaceuticals Provides Update on Regulatory Submission for Trofinetide for the Treatment of Rett Syndrome in the European Union

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Company was informed by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) of a ...

What we know about the contents of the recent release of Epstein files

More than 3 million newly-released pages of the Epstein files show more about the life and relationships of convicted sex offender Jeffrey Epstein. They also contain unredacted names of his accusers.

Acadia Pharmaceuticals Inc.: Acadia Pharmaceuticals Provides Update on Regulatory Submission for Trofinetide for the Treatment of Rett Syndrome in the European Union

Company expects to receive a negative opinion following oral explanation feedback and intends to request re-examination upon review of formal adoption. Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) ...